NantHealth raised $320 million in a round led by Kuwait Investment Authority (KIA) with participation from Verizon, Celgene, BlackBerry, and Blackstone. KIA contributed $250 million to the round, according to Nant. This brings the company's total funding to north of $400 million.
NantHealth offers a cloud-based, clinical decision support platform used by at least 250 hospitals, according to the company. Nant offers a range of services, including a population health platform and a suite of products built to provide a learning system for the treatment of cancer.
In addition to the funding, NantHealth announced that former WebMD COO, United Healthcare CIO, and VantageMed CEO Steve Curd was hired as NantHealth's Chief Operating Officer. The company also hired former Strand Diagnostics President and Genomics Health Vice President of US Sales Laura Beggrow as NantHealth's executive vice president of commercialization.
“Our new leadership team has the expertise, relationships and deep knowledge necessary to drive NantHealth forward and make our vision of transforming the healthcare system and delivering truly personalized medicine a reality,” NantHealth CEO and Founder Patrick Soon-Shiong said in a statement. “Their addition to the company along with KIA’s continued investments show the strength and confidence in NantHealth’s ability to deliver on 21st century medicine and value-based population health care.”
NantHealth is something of a rollup since it includes a number of acquisitions over the years, like medication adherence offering Vitality GlowCaps and the home health technology provider Boston Life Labs. Nant Health also invested $8 million in Fluential, in November 2013, a stealthy but longstanding company working on “of speech optimization and deep language understanding tools for mobile devices, wearables and consumer ‘personal assistant’ applications."